Infection, oxygen, and immaturity: Interacting risk factors for retinopathy of prematurity

Neonatology

Volumn 99, Issue 2, 2011, Pages 125-132

  Chen, Minghua ^a   Çitil, Ayse ^a   McCabe, Frank ^b   Leicht, Katherine M ^a   Fiascone, John ^a   Dammann, Christiane E L ^a,d   Dammann, Olaf ^a,c,e  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d Department of Pediatric Pulmonology and Neonatology ^*  (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Gestational age; Infection; Oxygen; Retinopathy of prematurity; Risk factors

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BIRTH WEIGHT; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HIGH FREQUENCY VENTILATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEWBORN; NEWBORN SEPSIS; PATENT DUCTUS ARTERIOSUS; PREDICTIVE VALIDITY; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; RISK FACTOR; STAPHYLOCOCCUS INFECTION; STEROID THERAPY;

CASE-CONTROL STUDIES; COHORT STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; OXYGEN INHALATION THERAPY; PROSPECTIVE STUDIES; RETINOPATHY OF PREMATURITY; SEPSIS;

EID: 77956078367     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000312821     Document Type: Article

References (61)

1. Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, et al: The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005, 116:15-23.
2. Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats DK: Childhood blindness. J Aapos 1999; 3: 26-32.
3. Clark D, Mandal K: Treatment of retinopathy of prematurity. Early Hum Dev 2008; 84: 95-99. (Pubitemid 351226474)
4. Kinsey VE, Arnold HJ, Kalina RE, Stern L, Stahlman M, Odell G, et al: PaO 2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics 1977; 60: 655-668. (Pubitemid 8242419)
5. Patz A, Hoeck LE, De La Cruz E: Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol 1952; 35: 1248-1253.
6. Tin W, Milligan DW, Pennefather P, Hey E: Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed 2001; 84:F106-F110. (Pubitemid 32250852)
7. Anderson CG, Benitz WE, Madan A: Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. J Perinatol 2004; 24: 164-168. (Pubitemid 38515155)
8. Ashton N, Ward B, Serpell G: Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report. Br J Ophthalmol 1953; 37: 513-520.
9. Maheshwari R, Kumar H, Paul VK, Singh M, Deorari AK, Tiwari HK: Incidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi. Natl Med J India 1996; 9: 211-214. (Pubitemid 126459613)
10. Liu PM, Fang PC, Huang CB, Kou HK, Chung MY, Yang YH, et al: Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g. Am J Perinatol 2005; 22: 115-120.
11. Manzoni P, Maestri A, Leonessa M, Mostert M, Farina D, Gomirato G: Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates. J Perinatol 2006; 26: 23-30. (Pubitemid 43135251)
12. Holmstrom G, Broberger U, Thomassen P: Neonatal risk factors for retinopathy of prematurity - a population-based study. Acta Ophthalmol Scand 1998; 76: 204-207. (Pubitemid 28177211)
13. Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, et al: Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001; 98: 5804-5808. (Pubitemid 32435723)
14. Dordelmann M, Kerk J, Dressler F, Brinkhaus MJ, Bartels DB, Dammann CE, et al: Interleukin- 10 high producer allele and ultrasound- defined periventricular white matter abnormalities in preterm infants: a preliminary study. Neuropediatrics 2006; 37: 130-136. (Pubitemid 44450282)
15. Sarlos S, Rizkalla B, Moravski CJ, Cao Z, Cooper ME, Wilkinson-Berka JL: Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. Am J Pathol 2003; 163: 879-887. (Pubitemid 37040124)
16. Lucey JF, Dangman B: A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics 1984; 73: 82-96. (Pubitemid 14221953)
17. Berrington De Gonzalez A, Cox DR: Interpretation of interaction: a review. Ann Appl Stat 2007; 1: 371-385.
18. Kenneth Rothman SG: Modern Epidemiology. Philadelphia, Lippincott Williams & Wilkins, 1998.
19. Aschengrau A, Seage GR: Essentials of Epidemiology in Public Health. Sudbury, Jones and Bartlett, 2003.
20. Noyola DE, Bohra L, Paysse EA, Fernandez M, Coats DK: Association of candidemia and retinopathy of prematurity in very low birthweight infants. Ophthalmology 2002; 109: 80-84. (Pubitemid 34027427)
21. Karlowicz MG, Giannone PJ, Pestian J, Morrow AL, Shults J: Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight ( < /= 1000 g) neonates? Pediatrics 2000; 105: 1036-1040. (Pubitemid 30243780)
22. Dammann O, Brinkhaus MJ, Bartels DB, Dordelmann M, Dressler F, Kerk J, et al: Immaturity, perinatal inflammation, and retinopathy of prematurity: a multi-hit hypothesis. Early Hum Dev 2009; 85: 325-329.
23. Vermont Oxford Network: Manual of operations (for infants born in 2008: release 12.1 2000). Burlington, Vermont, 2008. www. vtoxford.org/home.aspx?p=/ tools/downloads. htm.
24. Payne NR, Carpenter JH, Badger GJ, Horbar JD, Rogowski J: Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 2004; 114: 348-355. (Pubitemid 39006660)
25. International Committee for the Classification of Retinopathy of Prematurity: The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123: 991-999.
26. An international classification of retinopathy of prematurity. Pediatrics 1984; 74: 127-133.
27. Screening examination of premature infants for retinopathy of prematurity. A joint statement of the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology. Pediatrics 1997; 100: 273.
28. American Academy of Pediatrics. Section on Ophthalmology: Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2001; 108: 809-811.
29. Section on Ophthalmology American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus: Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006; 117: 572-576
30. erratum in: Pediatrics 2006; 118: 1324.
31. Arnold CC, Kramer MS, Hobbs CA, McLean FH, Usher RH: Very low birth weight: a problematic cohort for epidemiologic studies of very small or immature neonates. Am J Epidemiol 1991; 134: 604-613.
32. Khoury M: Modern Epidemiology, ed 2. Philadelphia, Lippincott Williams & Wilkins, 1998.
33. Bartlett MS: Contingency table interaction. J R Stat Soc 1935;(suppl 2):248-252.
34. Kim TI, Sohn J, Pi SY, Yoon YH: Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol 2004; 18: 130-134. (Pubitemid 38374265)
35. Seiberth V, Linderkamp O: Risk factors in retinopathy of prematurity: a multivariate statistical analysis. Ophthalmologica 2000; 214: 131-135. (Pubitemid 30179209)
36. Brown BA, Thach AB, Song JC, Marx JL, Kwun RC, Frambach DA: Retinopathy of prematurity: evaluation of risk factors. Int Ophthalmol 1998; 22: 279-283. (Pubitemid 30251255)
37. Chye JK, Lim CT, Leong HL, Wong PK: Retinopathy of prematurity in very low birth weight infants. Ann Acad Med Singapore 1999; 28: 193-198.
38. Gunn TR, Easdown J, Outerbridge EW, Aranda JV: Risk factors in retrolental fibroplasia. Pediatrics 1980; 65: 1096-1100. (Pubitemid 10068741)
39. Bharwani SK, Dhanireddy R: Systemic fungal infection is associated with the development of retinopathy of prematurity in very low birth weight infants: a meta-review. J Perinatol 2008; 28: 61-66.
40. Chen J, Smith LE: Retinopathy of prematurity. Angiogenesis 2007; 10: 133-140. (Pubitemid 46440629)
41. Flynn JT, Bancalari E, Snyder ES, Goldberg RN, Feuer W, Cassady J, et al: A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992; 326: 1050-1054.
42. Wright KW, Sami D, Thompson L, Ramanathan R, Joseph R, Farzavandi S: A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity. Trans Am Ophthalmol Soc 2006; 104: 78-84.
43. Wallace DK, Veness-Meehan KA, Miller WC: Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels. J Aapos 2007; 11: 170-174. (Pubitemid 46528779)
44. Vanderveen DK, Mansfield TA, Eichenwald EC: Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J Aapos 2006; 10: 445-448. (Pubitemid 44633728)
45. Deulofeut R, Critz A, Adams-Chapman I, Sola A: Avoiding hyperoxia in infants < or = 1250 g is associated with improved shortand long-term outcomes. J Perinatol 2006; 26: 700-705. (Pubitemid 44650189)
46. McGregor ML, Bremer DL, Cole C, McClead RE, Phelps DL, Fellows RR, et al: Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation 1 94% in room air: the high oxygen percentage in retinopathy of prematurity study. Pediatrics 2002; 110: 540-544. (Pubitemid 34976683)
47. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000; 105: 295-310.
48. Gaynon MW, Stevenson DK, Sunshine P, Fleisher BE, Landers MB: Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity. J Perinatol 1997; 17: 434-438. (Pubitemid 127453416)
49. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM: Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003; 349: 959-967. (Pubitemid 37064769)
50. Seiberth V LO, Akkoyun-Vardarli I, Jendritza W, Voegele C: Oxygen therapy in acute retinopathy of prematurity stage 3. Invest Ophthalmol Vis Sci 1998; 39:S820.
51. Chen M, Guo L, Smith L, Dammann C, Dammann O: High or low oxygen saturation and severe retinopathy of prematurity. Pediatrics 2010; 125:e1483-e1492.
52. Sears JE, Pietz J, Sonnie C, Dolcini D, Hoppe G: A change in oxygen supplementation can decrease the incidence of retinopathy of prematurity. Ophthalmology 2009; 116: 513-518.
53. Pierce EA, Foley ED, Smith LE: Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996; 114: 1219-1228. (Pubitemid 26338853)
54. Hellstrom A, Carlsson B, Niklasson A, Segnestam K, Boguszewski M, de Lacerda L, et al: IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab 2002; 87: 3413-3416. (Pubitemid 34816398)
55. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al: Changes in pathogens causing early-onset sepsis in verylow- birth-weight infants. N Engl J Med 2002; 347: 240-247. (Pubitemid 34787630)
56. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al: Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-291. (Pubitemid 34833012)
57. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al: Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292: 2357-2365. (Pubitemid 39491920)
58. Cats BP, Tan KE: Retinopathy of prematurity: review of a four-year period. Br J Ophthalmol 1985; 69: 500-503. (Pubitemid 15069220)
59. Hussain N, Clive J, Bhandari V: Current incidence of retinopathy of prematurity, 1989- 1997. Pediatrics 1999; 104:e26.
60. Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, et al: Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007; 13: 868-873. (Pubitemid 47038185)
61. Buras JA, Holt D, Orlow D, Belikoff B, Pavlides S, Reenstra WR: Hyperbaric oxygen protects from sepsis mortality via an interleukin- 10-dependent mechanism. Crit Care Med 2006; 34: 2624-2629. (Pubitemid 44413063)